Hydrogel Rectal Spacer: Radiopaque vs. Non-radiopaque
Richard G. Stock, MD, explores the role of rectal spacers in reducing gastrointestinal toxicity during prostate cancer radiotherapy.
Read More
Integrated Medical Professionals PLC
Adaptive Radiotherapy
In this 23-minute presentation, Richard D. Stock, MD, explores integrating artificial intelligence in radiation oncology, focusing on adaptive radiation therapy (ART). Three categories of ART—offline, online, and real-time—are detailed, explaining their respective timelines, imaging technologies, and resource requirements. The discussion critically evaluates ART in prostate cancer, where anatomical shifts due to bladder or rectal changes can influence treatment accuracy.
Examples of imaging technologies like MRI and PET scans are discussed for their contributions to ART’s precision and potential to adapt treatment based on tumor shrinkage or biological response. Comparative studies from the Netherlands and other institutions demonstrate ART’s ability to refine target margins, decrease normal tissue exposure, and predict patient outcomes more accurately.
As ART shows promise in improving treatment precision, Dr. Stock emphasizes its potential for advancing radiation oncology, driven by technological innovation and ongoing research.
Read More
mCRPC: Lu-177 PSMA and Beyond
William K. Oh, MD, discusses prostate cancer diagnosis and treatment, focusing on PSMA diagnostics and LU-177 PSMA therapy.
Read More
Systemic Immunotherapy in Prostate Cancer
William K. Oh, MD, discusses systemic immunotherapy approaches for advanced prostate cancer.
Read More
2019 Economic Outlook for Urology in the United States
Deepak A. Kapoor, MD, FACS, discusses the history of efforts in the United States to transition healthcare toward a structure of value-based care. He then outlines major 2019 regulatory initiatives and how they will impact healthcare payments and the administrative burden for urologists.
Read More